Ramsay Health Care Australia has been let off the hook for using emails subpoenaed in a defamation case between two feuding surgeons at one of its hospitals, with a judge accepting that an in-house lawyer was “mortified” by her mistake and was “drowning in work” at the time.
The judge overseeing the scandal-ridden Banksia Securities class action has questioned why a solicitor on record for the case hasn’t handed over his ill-gotten fees despite professed regret for his actions and his claims to have reformed.
Former Bellamy’s Australia director Jan Cameron has filed proceedings against the Australian Taxation Office to avoid paying capital gains tax on the sale of 2.5 million shares in the organic baby food company 2018.
The NSW Court of Appeal has granted Bianca Rinehart’s bid for her billionaire mother Gina to hand over trust documents that could be used in a dispute over ownership of the $4 billion family trust.
The High Court has rejected plumbing company Repipe’s application to hear its case centred on the question of patent eligibility for computer-implemented inventions, saying the case was not an appropriate vehicle for special leave.
The behaviour of the legal team running the Banksia Securities class action was “reprehensible” and the solicitor who allowed himself to be controlled by lawyer and funder Mark Elliott should be struck from the court’s roll of practitioners, a judge heard Tuesday.
Eleven women will give evidence of sexually inappropriate behaviour by actor Craig McLachlan in his defamation case against Rocky Horror Show co-star Christie Whelan Browne and publishers ABC and Fairfax, including one actress who worked with him on the set of Neighbours in the late 1980s.
Moray & Agnew is facing a lawsuit by a former client who says the firm breached its duties by making an unauthorised $3.3 million transfer while representing him on an investment in a Melbourne storage facility development.
AMP has admitted two of its units charged customers fees for no service but denied it acted unconscionably in a case brought by the corporate regulator alleging it continued to charge advice fees and life insurance premiums to customers who had died.
Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.